Here are nine key notes on spine and orthopedic device companies: By Eric Oliver - 1/29/20

Collagen Matrix, acquired by private equity firm Linden Capital Partners last year, appointed Shawn McCarthy as CEO on Jan. 29. By Alan Condon - 1/29/20

Atlas Spine on Jan. 28 launched its V3 Guided Segmental Plating System, expanding treatments for complex deformity and degenerative conditions of the cervical spine. By Alan Condon - 1/29/20

San Antonio-based NuHope, an outpatient treatment center focused on reducing patient opioid dependency, appointed Jeff Dunkel as CEO on Jan. 28. By Alan Condon - 1/28/20

Zavation Medical Products' spine devices assisted surgeons in more than 10,000 kyphoplasty procedures last year. By Alan Condon - 1/28/20

Assure Holdings on Jan. 28 signed an agreement to provide intraoperative neuromonitoring services for a five-surgeon practice based in Western Colorado. By Alan Condon - 1/28/20

SpinalCyte changed its name Jan. 28 to FibroGenesis. By Alan Condon - 1/28/20

Stryker named Don Payerle president of joint replacement, effective March 1. By Laura Dyrda - 1/27/20

Baron Lonner, MD, of New York City-based Mount Sinai Health System, performed the first spinal tethering surgery in New York City to correct idiopathic scoliosis. By Eric Oliver - 1/27/20

Anika Therapeutics on Jan. 24 acquired privately-held sports medicine company Parcus Medical. By Alan Condon - 1/27/20

Rob Pace, cofounder and CFO of Osseus Fusion Systems, was appointed CEO Jan. 27. By Alan Condon - 1/27/20

A string of former Insys Therapeutics executives were handed prison sentences for their roles in an opioid kickback scheme involving its highly addictive painkiller, Subsys. By Alan Condon - 1/23/20

Centinel Spine on Jan. 23 extended its partnership as title sponsor for the Performance Tech Motorsports team through the 2020 IMSA WeatherTech SportsCar Championship season. By Alan Condon - 1/23/20

Misonix initiated an underwritten public offering of 1.62 million shares of its common stock Jan. 23, valued at $18.50 per share. By Alan Condon - 1/23/20

Here are three orthopedic and spine device companies that recently launched or released devices: By Eric Oliver - 1/23/20

Former Insys Therapeutics CEO Michael Babich was sentenced to 30 months in prison Jan. 22 for his role in a kickback scheme encouraging physicians to prescribe more opioids, Bloomberg Law reports. By Alan Condon - 1/22/20

Here are seven key notes on spine and orthopedic device companies:  By Eric Oliver - 1/22/20

Medtronic on Jan. 21 released three-month results from a clinical trial highlighting the effectiveness of Differential Target Multiplexed spinal cord stimulation in treating back pain, compared to traditional SCS. By Alan Condon - 1/22/20

The Intel board elected outgoing Medtronic CEO Omar Ishrak, PhD, as chairman, the company announced on Jan. 21. By Laura Dyrda - 1/22/20

Johnson & Johnson reported worldwide orthopedic sales of $8.8 billion in 2019, a 0.5 percent dip compared to 2018. By Laura Dyrda - 1/22/20